Treatment of Membranous Nephropathy With Crescent Nephritis by Rituximab With Corticosteroids

被引：0
|
作者：
Zhang, Fan [1 ]
Yang, Yiya [1 ]
Chen, Yinyin [1 ]
Liang, Yumei [1 ]
Luo, Xun [1 ]
机构：
[1] Hunan Prov Peoples Hosp, Changsha, Peoples R China
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO721
引用
收藏
页码：802 / 802
页数：1
相关论文
共 50 条
  • [1] Treatment of membranous nephropathy with crescent nephritis by rituximab: A case report
    Zhang, Fan
    Yang, Yiya
    Chen, Yinyin
    Chen, Ying
    Yin, Wei
    Liang, Yumei
    Luo, Xun
    MEDICINE, 2022, 101 (37) : E30663
  • [2] Treatment with rituximab in idiopathic membranous nephropathy
    Fiorentino, Marco
    Tondolo, Francesco
    Bruno, Francesca
    Infante, Barbara
    Grandaliano, Giuseppe
    Gesualdo, Loreto
    Manno, Carlo
    CLINICAL KIDNEY JOURNAL, 2016, 9 (06) : 788 - 793
  • [3] Rituximab treatment of idiopathic membranous nephropathy
    Fervenza, F. C.
    Cosio, F. G.
    Erickson, S. B.
    Specks, U.
    Herzenberg, A. M.
    Dillon, J. J.
    Leung, N.
    Cohen, I. M.
    Wochos, D. N.
    Bergstralh, E.
    Hladunewich, M.
    Cattran, D. C.
    KIDNEY INTERNATIONAL, 2008, 73 (01) : 117 - 125
  • [4] Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
    Fervenza, F. C.
    Appel, G. B.
    Barbour, S. J.
    Rovin, B. H.
    Lafayette, R. A.
    Aslam, N.
    Jefferson, J. A.
    Gipson, P. E.
    Rizk, D. V.
    Sedor, J. R.
    Simon, J. F.
    McCarthy, E. T.
    Brenchley, P.
    Sethi, S.
    Avila-Casado, C.
    Beanlands, H.
    Lieske, J. C.
    Philibert, D.
    Li, T.
    Thomas, L. F.
    Green, D. F.
    Juncos, L. A.
    Beara-Lasic, L.
    Blumenthal, S. S.
    Sussman, A. N.
    Erickson, S. B.
    Hladunewich, M.
    Canetta, P. A.
    Hebert, L. A.
    Leung, N.
    Radhakrishnan, J.
    Reich, H. N.
    Parikh, S. V.
    Gipson, D. S.
    Lee, D. K.
    da Costa, B. R.
    Juni, P.
    Cattran, D. C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 36 - 46
  • [5] Rituximab in Membranous Nephropathy
    Gauckler, Philipp
    Shin, Jae Il
    Alberici, Federico
    Audard, Vincent
    Bruchfeld, Annette
    Busch, Martin
    Cheung, Chee Kay
    Crnogorac, Matija
    Delbarba, Elisa
    Eller, Kathrin
    Faguer, Stanislas
    Galesic, Kresimir
    Griffin, Sian
    van den Hoogen, Martijn W. F.
    Hruskova, Zdenka
    Jeyabalan, Anushya
    Karras, Alexandre
    King, Catherine
    Kohli, Harbir Singh
    Mayer, Gert
    Maas, Rutger
    Muto, Masahiro
    Moiseev, Sergey
    Odler, Balazs
    Pepper, Ruth J.
    Quintana, Luis F.
    Radhakrishnan, Jai
    Ramachandran, Raja
    Salama, Alan D.
    Schonermarck, Ulf
    Segelmark, Marten
    Smith, Lee
    Tesar, Vladimir
    Wetzels, Jack
    Willcocks, Lisa
    Windpessl, Martin
    Zand, Ladan
    Zonozi, Reza
    Kronbichler, Andreas
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 881 - 893
  • [6] Rituximab in membranous nephropathy
    Ring, Troels
    KIDNEY INTERNATIONAL, 2008, 74 (03) : 391 - 392
  • [7] The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
    Fernandez-Juarez, Gema
    Rojas-Rivera, Jorge
    van de Logt, Anne-Els
    Justino, Joana
    Sevillano, Angel
    Caravaca-Fontan, Fernando
    Avila, Ana
    Rabasco, Cristina
    Cabello, Virginia
    Varela, Alfonso
    Diez, Montserrat
    Martin-Reyes, Guillermo
    Goicoechea Diezhandino, Marian
    Quintana, Luis F.
    Agraz, Irene
    Ramon Gomez-Martino, Juan
    Cao, Mercedes
    Rodriguez-Moreno, Antolina
    Rivas, Begona
    Galeano, Cristina
    Bonet, Jose
    Romera, Ana
    Shabaka, Amir
    Plaisier, Emmanuelle
    Espinosa, Mario
    Egido, Jesus
    Segarra, Alfonso
    Lambeau, Gerard
    Ronco, Pierre
    Wetzels, Jack
    Praga, Manuel
    KIDNEY INTERNATIONAL, 2021, 99 (04) : 986 - 998
  • [8] Rituximab in Membranous Nephropathy: Is It a First-Line Treatment?
    Appel, Gerald B.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (08): : 1280 - 1282
  • [9] Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: CON
    van de Logt, Anne-Els
    Wetzels, Jack F.
    KIDNEY360, 2021, 2 (11): : 1699 - 1701
  • [10] Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARY
    Klomjit, Nattawat
    Zand, Ladan
    KIDNEY360, 2021, 2 (11): : 1702 - 1705
12345